Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Incyte agrees to licence three products to Innovent Biologics

pharmaceutical-technologyDecember 19, 2018

Tag: Incyte , Innovent Biologics , FGFR inhibitor , Pemigatinib

PharmaSources Customer Service